Summary
This prediction ended on 26.03.24 with a price of €27.13. The prediction for Bayer AG disappointed with a performance of -15.23%. Snowman has a follow-up prediction for Bayer AG where he still thinks Bayer AG is a Buy. Snowman has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bayer AG | 4.428% | 4.428% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
According to Snowman what are the pros and cons of Bayer AG for the foreseeable future?
Pros
Undervalued
Well known brand
Future proof or reliable business model
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Strong uniques